HazMat Fee + There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
| Type | HazMat fee for 500 gram (Estimated) |
| Excepted Quantity | USD 0.00 |
| Limited Quantity | USD 15-60 |
| Inaccessible (Haz class 6.1), Domestic | USD 80+ |
| Inaccessible (Haz class 6.1), International | USD 150+ |
| Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
| Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 产品名称 | Telomerase ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4',7-Dimethoxyisoflavone | ✔ | 97% | |||||||||||||||||
| BIBR 1532 |
+++
Telomerase, IC50: 100 nM |
99%+ | |||||||||||||||||
| Costunolide |
++
Telomerase (MCF-7), IC50: 90 μM Telomerase (MDA-MB-231), IC50: 65 μM |
98% | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 描述 | MST-312, also called Telomerase inhibitor IX, is a synthetic compound that acts as a reversible TERT (telomerase) inhibitor, and is described to be more potent than epigallocatechin gallate. |
| Concentration | Treated Time | Description | References | |
| HT-29 | 10 µM | 24 hours | Inhibited telomerase activity, reduced CD133 (+) subpopulation | Int J Oncol. 2016 Aug;49(2):487-98 |
| MDA-MB-231 | 10 µM | 24 hours | Reduced CD44 (+) subpopulation, inhibited wound healing capacity | Int J Oncol. 2016 Aug;49(2):487-98 |
| SW620 | 10 µM | 24 hours | Inhibited telomerase activity, reduced CD133 (+) subpopulation | Int J Oncol. 2016 Aug;49(2):487-98 |
| KNS60 cells | 1.0 μM | 48 hours | Assessed the inhibitory effect of MST-312 on telomerase activity, showing inhibition. | Mol Cancer. 2014 Oct 13;13:232 |
| MO59K cells | 1.0 μM | 48 hours | Assessed the inhibitory effect of MST-312 on telomerase activity, showing reversible inhibition. | Mol Cancer. 2014 Oct 13;13:232 |
| ONS76 cells | 1.0 μM | 48 hours | Assessed the inhibitory effect of MST-312 on telomerase activity, showing dose-dependent inhibition. | Mol Cancer. 2014 Oct 13;13:232 |
| OSE (Human Ovarian Surface Epithelial cells) | 0.01–50 µM | 72 hours | MST-312 had an IC50 of 8 µM in OSE cells and showed cytoprotective effects at low concentrations. | Transl Oncol. 2023 Jan;27:101569 |
| HCT116 (colorectal carcinoma) | 0.01–50 µM | 72 hours | MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 5.9 µM. | Transl Oncol. 2023 Jan;27:101569 |
| A2780cisR (ovarian adenocarcinoma cisplatin-resistant cell line) | 0.01–50 µM | 72 hours | MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 3.6 µM. | Transl Oncol. 2023 Jan;27:101569 |
| OVCAR3 (ovarian adenocarcinoma cell line) | 0.01–50 µM | 72 hours | MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 7.1 µM. | Transl Oncol. 2023 Jan;27:101569 |
| A2780 (ovarian adenocarcinoma cell line) | 0.01–50 µM | 72 hours | MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 3.9 µM. | Transl Oncol. 2023 Jan;27:101569 |
| PA-1 (ovarian teratocarcinoma cell line) | 0.01–50 µM | 72 hours | MST-312 induced cytotoxicity in a dose-dependent manner with IC50 of 4.2 µM. | Transl Oncol. 2023 Jan;27:101569 |
| H1299 cells | 0.25 μM | 120 hours | MST312 significantly inhibited H1299 cell proliferation, with ALDH+ cells being more sensitive than ALDH- cells. | Mol Cancer. 2011 Aug 9;10:96 |
| H460 cells | 1 μM | 120 hours | MST312 exhibited a dose-dependent antiproliferative effect on H460 cells, with ALDH+ cells being more sensitive than ALDH- cells. | Mol Cancer. 2011 Aug 9;10:96 |
| MDA-MB-435 | 0.23 μM (IC50) | 24 hours | To investigate the inhibitory effect of MST-312 on telomerase activity and its impact on cancer cell survival. Results showed that MST-312 inhibited telomerase activity in a concentration-dependent manner with an IC50 of 0.23 μM. | Eur J Med Chem. 2017 Jan 5;125:117-129 |
| primary ependymoma cells | 0 to 4 μM | 72 hours | To evaluate the effect of MST-312 on cell viability. Results showed a significant decrease in cell number (P<0.001), increased DNA damage (γH2AX expression, P<0.01), decreased proliferative index (MIB-1, P<0.01), and increased apoptosis in some cells (cleaved caspase 3). | Brain Pathol. 2010 Jul;20(4):780-6 |
| NCI-H441 cells | 2.5 μM | 28 days | Induced cellular senescence and increased secretion of pro-inflammatory cytokines | Respir Res. 2011 Jun 10;12(1):78 |
| Leishmania major promastigote cells | 0.1 to 4 µM | 30 minutes | To test the effect of human telomerase inhibitors on L. major telomerase activity. Both MST-312 and TMPyP4 effectively inhibited L. major telomerase activity, with MST-312 being more potent, achieving complete inhibition at 0.5µM, which is eight times lower than the concentration required for TMPyP4. | Microorganisms. 2025 Feb 7;13(2):357 |
| FLO-1 cells | 1 μM | 10 days | To evaluate the antiproliferative effect of MST-312 analog GRN163L on H460 cells, results showed that SFN enhanced the activity of GRN163L. | Transl Oncol. 2010 Dec 1;3(6):389-99 |
| HEp-2 cells | 20-100 μM | 18 hours | MST-312 inhibits HSV-1 replication, reduces viral protein accumulation. | J Virol. 2015 Oct;89(19):9804-16 |
| hTERT-HME1 cells | 20-100 μM | 18 hours | MST-312 inhibits HSV-1 replication, reduces cytopathic effects and viral protein accumulation. | J Virol. 2015 Oct;89(19):9804-16 |
| Administration | Dosage | Frequency | Description | References | ||
| Athymic mice | H460 xenograft model | Intraperitoneal injection | 40 mg/kg | Once daily for 25 days | MST312 significantly reduced tumor volume (70% reduction), decreased the number of ALDH+ CSCs, and induced apoptosis. | Mol Cancer. 2011 Aug 9;10:96 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
2.63mL 0.53mL 0.26mL |
13.15mL 2.63mL 1.31mL |
26.29mL 5.26mL 2.63mL |
|
| CAS号 | 368449-04-1 |
| 分子式 | C20H16N2O6 |
| 分子量 | 380.35 |
| SMILES Code | O=C(NC1=CC=CC(NC(C2=CC=CC(O)=C2O)=O)=C1)C3=CC=CC(O)=C3O |
| MDL No. | MFCD24368986 |
| 别名 | Telomerase Inhibitor IX |
| 运输 | 蓝冰 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 120 mg/mL(315.5 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1